• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $LITS

    Lite Strategy Inc.

    Subscribe to $LITS
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2003

    Exchange: NASDAQ

    Recent Analyst Ratings for Lite Strategy Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    Lite Strategy Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Flynn James P was granted 10,000 shares, increasing direct ownership by 127% to 17,900 units (SEC Form 4)

    4 - Lite Strategy, Inc. (0001262104) (Issuer)

    10/2/25 4:00:27 PM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lite Strategy Inc. SEC Filings

    View All

    SEC Form 10-K filed by Lite Strategy Inc.

    10-K - Lite Strategy, Inc. (0001262104) (Filer)

    9/26/25 4:00:57 PM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care